Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 16-Dec-21 9:30 PM View:  | Arvinas, Inc. (ARVN) | 16-Dec-21 | Market Sale | 85,705 | $69.36 | $5,944,420.00 | (32%) 271.39K to 185.69K | < 1% |
| 16-Dec-21 9:30 PM View: | Arvinas, Inc. (ARVN) | 15-Dec-21 | Market Sale | 113,536 | $66.81 | $7,584,960.00 | (29%) 384.93K to 271.39K | (4%) |
| 16-Dec-21 9:30 PM View: | Arvinas, Inc. (ARVN) | 14-Dec-21 | Market Sale | 156,464 | $65.86 | $10,304,000.00 | (29%) 541.39K to 384.93K | (5%) |
| 15-Nov-21 9:45 PM View: | Arvinas, Inc. (ARVN) | 15-Nov-21 | Market Sale | 21,284 | $84.87 | $1,806,470.00 | (4%) 562.67K to 541.39K | < 1% |
| 15-Nov-21 9:45 PM View: | Arvinas, Inc. (ARVN) | 12-Nov-21 | Market Sale | 39,869 | $84.94 | $3,386,460.00 | (7%) 602.54K to 562.67K | < 1% |
| 15-Nov-21 9:45 PM View: | Arvinas, Inc. (ARVN) | 11-Nov-21 | Market Sale | 59,799 | $86.23 | $5,156,390.00 | (9%) 662.34K to 602.54K | 2% |
| 15-Nov-21 9:45 PM View: | Arvinas, Inc. (ARVN) | 10-Nov-21 | Market Sale | 13,358 | $88.20 | $1,178,190.00 | (2%) 675.7K to 662.34K | 4% |
| 09-Nov-21 9:47 PM View: | Arvinas, Inc. (ARVN) | 09-Nov-21 | Market Sale | 33,008 | $91.97 | $3,035,860.00 | (5%) 708.71K to 675.7K | |
| 09-Nov-21 9:47 PM View: | Arvinas, Inc. (ARVN) | 08-Nov-21 | Market Sale | 81,054 | $94.45 | $7,655,880.00 | (10%) 789.76K to 708.71K | |
| 09-Nov-21 9:47 PM View: | Arvinas, Inc. (ARVN) | 05-Nov-21 | Option Exercise | 18,423 | $29.56 | $544,531.00 | 2% 829.36K to 847.78K | |
| 09-Nov-21 9:47 PM View: | Arvinas, Inc. (ARVN) | 05-Nov-21 | Market Option Sale | 18,423 | $91.30 | $1,681,940.00 | (2%) 847.78K to 829.36K | |
| 09-Nov-21 9:47 PM View: | Arvinas, Inc. (ARVN) | 05-Nov-21 | Market Sale | 6,500 | $91.30 | $593,422.00 | (< 1%) 829.36K to 822.86K | |
| 09-Nov-21 9:47 PM View: | Arvinas, Inc. (ARVN) | 05-Nov-21 | Market Sale | 33,094 | $91.84 | $3,039,320.00 | (4%) 822.86K to 789.76K | |
| 21-Dec-20 6:00 PM View: | Arvinas, Inc. (ARVN) | 18-Dec-20 | Market Purchase | 142,857 | $70.00 | $9,999,990.00 | 21% 680.0K to 822.86K | 13% |
| 27-May-20 6:34 PM View: | Arvinas, Inc. (ARVN) | 26-May-20 | Option Exercise | 6,500 | $22.06 | $143,390.00 | < 1% 680.0K to 686.5K | (12%) |
| 03-Mar-20 6:48 PM View: | Passage Bio, Inc. (PASG) | 03-Mar-20 | Purchase | 2,800 | $18.00 | $50,400.00 | 100% 0 to 2.8K | |
| 14-Nov-19 4:23 PM View: | Arvinas, Inc. (ARVN) | 12-Nov-19 | Private Purchase | 680,000 | $22.00 | $14,960,000.00 | 100% 0 to 680.0K | (12%) |
| 18-Mar-19 5:52 PM View: | Pds Biotechnology Corp (PDSB) | 15-Mar-19 | Option Exercise | 10,000 | -- | -- | < 1% 2.34M to 2.35M | |
| 03-Oct-18 5:22 PM View: | Arvinas, Inc. (ARVN) | 01-Oct-18 | Conversion | 1,283,050 | -- | -- | 100% 0 to 1.28M | |
| 03-Oct-18 5:22 PM View: | Arvinas, Inc. (ARVN) | 01-Oct-18 | Purchase Duplicate | 1,000,000 | $16.00 | $16,000,000.00 | 78% 1.28M to 2.28M | |
| 26-Jun-18 4:53 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Conversion Duplicate | 3,040,080 | -- | -- | 100% 0 to 3.04M | |
| 26-Jun-18 4:53 PM View: | Aptinyx Inc. (APTX) | 25-Jun-18 | Purchase | 250,000 | $16.00 | $4,000,000.00 | 8% 3.04M to 3.29M | |
| 03-Apr-18 4:30 PM View: | Cogent Biosciences, Inc. (COGT) | 03-Apr-18 | Conversion | 1,245,540 | -- | -- | 100% 0 to 1.25M | |
| 03-Apr-18 4:30 PM View: | Cogent Biosciences, Inc. (COGT) | 03-Apr-18 | Purchase | 550,000 | $12.00 | $6,600,000.00 | 44% 1.25M to 1.8M | |
| 02-Oct-17 4:40 PM View: | Deciphera Pharmaceuticals, ... (DCPH) | 02-Oct-17 | Conversion | 3,729,140 | -- | -- | 100% 0 to 3.73M | |
| 02-Oct-17 4:40 PM View: | Deciphera Pharmaceuticals, ... (DCPH) | 02-Oct-17 | Private Purchase | 375,000 | $17.00 | $6,375,000.00 | 10% 3.73M to 4.1M | |
| 30-Sep-13 5:46 PM View: | Array BioPharma, Inc. (ARRY) | 27-Sep-13 | Market Sale | 863,521 | $5.99 | $5,170,760.00 | (100%) 863.52K to 0 | (373%) |
| 30-Sep-13 5:46 PM View: | Array BioPharma, Inc. (ARRY) | 26-Sep-13 | Market Sale | 262,207 | $6.02 | $1,578,960.00 | (23%) 1.13M to 863.52K | (370%) |
| 16-Sep-13 5:48 PM View: | Array BioPharma, Inc. (ARRY) | 16-Sep-13 | Market Sale | 319,033 | $6.14 | $1,957,650.00 | (22%) 1.44M to 1.13M | (361%) |
| 16-Sep-13 5:48 PM View: | Array BioPharma, Inc. (ARRY) | 13-Sep-13 | Market Sale | 546,660 | $6.01 | $3,287,670.00 | (27%) 1.99M to 1.44M | (371%) |
| 16-Sep-13 5:48 PM View: | Array BioPharma, Inc. (ARRY) | 12-Sep-13 | Market Sale | 807,479 | $6.10 | $4,923,120.00 | (29%) 2.8M to 1.99M | (364%) |
| 06-Sep-13 5:10 PM View: | Array BioPharma, Inc. (ARRY) | 06-Sep-13 | Market Sale | 139,572 | $5.68 | $793,202.00 | (5%) 2.94M to 2.8M | (398%) |
| 06-Sep-13 5:10 PM View: | Array BioPharma, Inc. (ARRY) | 05-Sep-13 | Market Sale | 201,598 | $5.77 | $1,163,520.00 | (6%) 3.14M to 2.94M | (391%) |
| 06-Sep-13 5:10 PM View: | Array BioPharma, Inc. (ARRY) | 04-Sep-13 | Market Sale | 236,116 | $5.87 | $1,385,620.00 | (7%) 3.38M to 3.14M | (382%) |